CoreScan is a new software for the GE Lunar iDXA, which provides a quantification of visceral adipose tissue (VAT). The objective of this study was to determine the in vivo precision of CoreScan for the measurement of VAT mass in a heterogeneous group of adults. Forty-five adults (aged 34.6 (8.6) years), ranging widely in body mass index (BMI 26.0 (5.2) kg/m 2 ; 16.7-42.4 kg/m 2 ), received two consecutive total body scans with repositioning. The sample was divided into two subgroups based on BMI, normal-weight and overweight/obese, for precision analyses. Subgroup analyses revealed that precision errors (RMSSD:%CV; root mean square standard deviation:% coefficient of variation) for VAT mass were 20.9 g:17.0% in the normal-weight group and 43.7 g:5.4% in overweight/obese groups. Our findings indicate that precision for DXA-VAT mass measurements increases with BMI, but caution should be used with %CV-derived precision error in normal BMI subjects.
INTRODUCTION
Clinical investigations have demonstrated close relationships between regional fat mass and disease risk, namely the association of trunk fat, with the clustering of cardio-metabolic risk factors associated with metabolic syndrome. 1 Abdominal obesity is also an independent predictor of all-cause mortality. 2 Computed tomography (CT) is the gold-standard assessment of visceral adipose tissue (VAT), but it is expensive and the high-radiation exposure renders CT unsuitable as a screening tool. Dual-energy X-ray absorptiometry (DXA) provides a precise and less expensive measurement of three-compartment body composition. 3 GE has recently introduced CoreScan: a new tool for the quantification of VAT, which has been validated with CT in healthy men and women. 4 The advantages of using DXA over CT include the lower radiation exposure and greater time efficiency. It is important to determine the in vivo precision for all DXA outcomes for the interpretation of results and patient monitoring. The purpose of this study was to ascertain the short-term in vivo precision of the GE Lunar iDXA CoreScan software (GE Healthcare, Madison, WI, USA) for the measurement of VAT mass in normalweight, overweight and obese adults.
SUBJECTS AND METHODS
Forty-five men (n = 10) and women (n = 35) received two consecutive total-body DXA scans with repositioning, after providing signed informed consent to participate in the study approved by the Institution's Research Ethics Committee and in accordance with the Declaration of Helsinki.
Participants were measured wearing light-weight clothing, and all jewellery was removed. Height was determined with a stadiometer (SECA, Birmingham, UK) to the nearest 0.1 cm, and body weight was recorded by calibrated electronic scales (SECA, Birmingham, UK) to the nearest 0.1 kg. Body mass index (BMI) was calculated in kg/m 2 . Scans were conducted on a fan-beam GE Lunar iDXA using standard (153 mm/s) or thick (80 mm/s) mode depending on the body stature. Participants were placed in supine position on the scanning table with the body aligned with the central horizontal axis. Arms were positioned parallel to, but not touching, the body. Forearms were pronated with hands flat on the bed. Legs were fully extended and feet were secured with a canvas and velcro support to avoid foot movement during the scan acquisition. Each participant was repositioned between scans, after dismounting the scanning table. One skilled technologist led and analysed all scans according to the manufacturer's guidelines for patient positioning. Identical scanning parameters were used for each scan. The regions of interest for the total-body cut-offs were manually adjusted according to the manufacturer's instructions. The regions of interest over the android region for the assessment of VAT was automated by the software. Scan analyses were performed using the Lunar Encore software (Version 15, GE Healthcare). The machine's calibration was checked and passed on a daily basis using the GE Lunar calibration hydroxyapatite and epoxy resin phantom. There was no significant drift in calibration for the study period.
Data analysis was computed using Microsoft Excel 2010 and IBM SPSS Statistics software (Version 21, IBM, Armonk, NY, USA). Participant descriptive data are reported as the mean and s.d. The precision error is represented as the square root of the mean of the sum of the squares of differences between measurement 1 and measurement 2. The precision parameters, root mean square standard deviation (RMSSD) and %CV (coefficient of variation) and the resulting least significant changes (LSC) were calculated manually. The %CV is derived from the following equation: %CV = (s.d./mean value) × 100. Bland-Altman analysis was used to compare the paired measurements. 5 
RESULTS AND DISCUSSION
According to the World Health Organization BMI criteria, 4% of the participants were underweight (n = 2), 47% were classified as normal weight (n = 21), 29% were overweight (n = 13) and 20% were obese (n = 9). For analysis, the underweight and normalweight category were combined to form the 'normal-weight group' (n = 20 female, n = 3 male; age: 33.2 (8.6) years; BMI: 22.1 (2.2) kg/m 2 , range: 16.7-24.9 kg/m 2 ). The overweight and obese categories were also combined (n = 15 female, n = 7 male; age: 35.9 ( The mean difference between the two measurements was small, but the range on inter-measurements differences was substantial for both the normal-weight (−2.3 ± 30.2 g) and the overweight/obese group (15.9 ± 61.1 g). No magnitude effects were observed from Bland-Altman analysis. Table 1 shows the VAT mass precision and LSC at 95% CI (95% confidence intervals) for both groups and precision values determined from previous studies. Using RMSSD, precision error was lower in the normal BMI group at 20.9 g, but it was increased with %CV at 17.0% compared with the overweight/obese group, where VAT precision errors were 43.7 g and 5.4%, respectively. This is owing to %CV being dependant on its inverse relationship with the mean value. In this study, the mean VAT values of the two groups were different: 123 g v 806 g, resulting in the observed differences in %CV. Therefore, the 95% CI derived from RMSSD is the more reliable estimate. Our precision estimates for the overweight/ obese group are in close agreement with the obese group precision values determined by Rothney et al. 6 In the study of severely obese subjects by Carver et al., 7 there is a marked increase in the RMSSD precision error, but only a small increase in the %CV precision error compared with the obese subjects, likely owing to the higher VAT mass mean value in the severely obese group.
We investigated precision error of the GE CoreScan VAT software in a heterogeneous sample of adults. This sample was representative of the usual research participants who attend our DXA centre. Using RMSSD, precision error was greater in the overweight/obese group (20.9 versus 43.7 g). Our values are similar to those reported by Rothney et al., 6 most likely owing to the similar mean VAT masses. Our findings differ from those of Carver et al. 7 who reported a RMSSD precision of 294 g for a severely obese group. We have represented gender in Figures  1a and b , to help visualise that no gender bias was evident across BMI groups, but unfortunately gender could not be appropriately investigated owing to the low numbers of men in our study and the need to use pooled data. Possible disparity in precision by gender should therefore provide a valuable avenue for future research. In addition, the focus of this report is primarily an instrument validation, and our sample comprised predominantly Caucasian, and thus we did not account for ethnic backgrounds. Subcutaneous and visceral fat percentages are thought to differ across ethnic groups; therefore, it would be interesting for future work to assess the applicability of our results to other ethnicities.
We, and others, have previously reported excellent in vivo precision for iDXA measurements of total fat mass and total lean mass, regardless of BMI. 3, 8 As suggested elsewhere, the visceral region is relatively small and the mathematical complexities to distinguish VAT from subcutaneous fat may lead to greater precision error. 6 This should be considered in decision making for patient screening and monitoring of adipose tissue. In conclusion, Precision of the iDXA for the measurement of visceral fatthe iDXA CoreScan provides good precision for VAT measurements for individuals with a BMI between 25.5 and 42.4 kg/m 2 . Collectively, with findings from previous studies, we recommend that %CV value for precision should not be used when study population mean values differ, as observed in this study.
